Elevra Lithium SEC Filings

Elevra Lithium Limited reported the results of its 2025 Annual General Meeting, where all resolutions put to shareholders were passed by poll. The adoption of the remuneration report received strong support, with about 98% of votes cast in favor. Shareholders also confirmed the elections of directors Dawne Hickton, Jeffrey Armstrong, Jorge Beristain and Christina Alvord, each receiving more than 96% support on the poll.

Investors approved the company’s equity-related items, including ratification of an agreement to issue options to RCF VIII, the approval of the Equity Incentive Plan and the issue of securities under it, and grants of short-term and long-term performance rights to the CEO and Managing Director. These outcomes indicate broad shareholder backing for Elevra’s current board, executive remuneration structure and incentive frameworks.

Elevra Lithium Limited reports the conversion of 10,649 unlisted performance rights into the same number of ordinary fully paid shares on 12/11/2025. These rights were held by key management person Sylvain Collard and exercised under the company’s Employee Share and Option Plan approved by shareholders.

After this transaction, Elevra Lithium has 169,329,111 ELV ordinary fully paid shares quoted on ASX. Unquoted securities comprise 1,760,737 ELVAM performance rights, 14,897 ELVAA options expiring on various dates at various prices, and 2,723,613 ELVAN options expiring 31-Dec-2028 with a $4.80 exercise price.

Elevra Lithium (NASDAQ: ELVR) filed a Form 6‑K summarizing Q1 FY26 operations and growth plans. The company produced 52,003 dmt of spodumene concentrate and sold 25,975 dmt with 69% recovery. Q1 FY26 revenue was $31 million, and unit operating cost was A$1,250 per dmt sold. Cash stood at $149 million as of 30 September 2025. Market capitalization was $754 million as of 31 October 2025, with 169 million shares outstanding as of 6 November 2025.

The merger of Sayona Mining and Piedmont Lithium created Elevra Lithium, consolidating North American Lithium (NAL) and targeting synergies across SG&A, logistics, and marketing. The NAL brownfield expansion scoping study outlines an increase to 315 ktpa, targeting C1 cash cost of US$562/t and AISC of US$680/t, with estimated initial capex of US$270 million and post‑tax NPV(8%) of US$950 million. A staged timetable anticipates permitting, construction, and ramp‑up through CY30.

FY26 guidance calls for 195,000–210,000 dmt of production and sales, unit operating costs of A$1,175–A$1,275 per dmt sold, and A$40 million in capital expenditures (A$30 million sustaining at NAL). Resource updates increased NAL to 95 Mt (1.15% Li2O) and reserves to 49 Mt, and Moblan to 121 Mt with 48.1 Mt in reserves.

Elevra Lithium Limited reported the ASX quotation of 582,770 ordinary fully paid shares (code ELV) issued on 30/10/2025 as part of a previously announced transaction. The shares were issued for no cash consideration, with an estimated value of A$3.90 per share.

Following this quotation, quoted ordinary shares on issue total 169,329,111. Unquoted securities include 1,771,386 performance rights, 14,897 options with various terms, and 2,723,613 options expiring 31-DEC-2028 with a A$4.80 exercise price.

Elevra Lithium Limited (ELVR) filed its annual report for the year ended June 30, 2025. The company, formerly Sayona Mining Limited, completed a merger on August 29, 2025 in which Piedmont Lithium Inc. became a wholly owned subsidiary; results in this report reflect Elevra only, prior to the merger. On September 16, 2025, Elevra executed a 150:1 share consolidation; each ADS now represents 10 ordinary shares and trades on Nasdaq under ELVR.

Elevra raised equity via placements at AU$0.032 per ordinary share: 1,250,000,000 shares on November 28, 2024 and 2,156,250,000 shares to Resource Capital Fund VIII on September 4, 2025. In connection with the latter, Elevra issued 2,723,613 options (post‑consolidation) and remains obligated to issue 5,276,387 additional options, each exercisable at AU$4.80 and expiring on December 31, 2028.

Commercial arrangements include an amended offtake with Tesla for approximately 99,000 dmt of spodumene concentrate through September 2026 and an offtake with LG Chem for 200,000 dmt through Q2 2028. A life‑of‑mine agreement with Lithium Royalty Corp. covers 10% of the Moblan project output attributable to Elevra’s subsidiary. The filing details risks typical of multi‑asset lithium development, including price volatility, project execution, financing needs, and post‑merger integration.

Elevra Lithium Limited reported the issuance of 287,500 new fully paid ordinary shares at $4.80 per share to CG Nominees (Australia) Pty Ltd. The shares were issued in satisfaction of remaining underwriting fees owed to Canaccord Genuity (Australia) Limited related to the Company’s conditional institutional placement announced on November 19, 2024 and approved by shareholders on July 31, 2025.

This is a non-cash settlement of fees via equity and follows an ASX notice made under section 708A(5)(e) of the Corporations Act 2001 (Cth). The announcement was authorized by Elevra’s Managing Director.

Elevra Lithium Limited reported the ASX quotation of 287,500 ordinary fully paid shares, issued as part of a previously announced placement, with an issue date of 28 October 2025. The shares were issued for non-cash consideration with an estimated value of A$4.80 per share.

Following this quotation, total quoted ordinary shares on issue are 168,746,341. The company also lists unquoted securities comprising 1,771,386 performance rights and options including 14,897 options (various terms) and 2,723,613 options expiring 31 December 2028 with a A$4.80 exercise price.

Elevra Lithium Limited (ELVR) filed a 6-K detailing a pivotal quarter marked by the completion of the Sayona–Piedmont merger, a rebrand, and a 150‑to‑1 share consolidation. The company closed a conditional capital raise of $69 million and ended 30 September 2025 with cash and cash equivalents of $148.8 million. At North American Lithium (NAL), spodumene concentrate production was 52,003 dmt at 5.2% grade, with sales of 25,975 dmt at an average realised price of $1,198/dmt (FOB), generating $31 million of revenue. Unit operating cost sold (FOB) was $1,250/dmt.

Safety performance improved materially, with no lost time injuries and 40 consecutive Triple Zero days. NAL shipments were deliberately weighted toward the December quarter, with 51,041 tonnes of finished goods stockpiled, in transit, or at port as of 30 September 2025. The NAL Expansion Scoping Study outlined an increase in plant feed to 6,500 tpd and an average ~315,000 tpa of 5.4% Li2O concentrate, with post‑tax NPV of C$1,284 million, IRR 26.4%, initial capex C$366 million, and C1 cash costs of C$759/t. Moblan’s updated resource stands at 121.0 Mt @ 1.19% Li2O, including 48.1 Mt @ 1.31% Li2O of Ore Reserves, a 39% increase.